KARACHI - GlaxoSmithKline (GSK) has reinforced its commitment to Pakistan by announcing it will increase investment in consumer health brands over the next five years, says a Press release.
It will do so via the introduction of new brands in its wellness, oral health and nutrition portfolios, said John Sayers, president of GSK Consumer Health of Asia, Pacific, Latin America and Middle East (APLAM) at a press conference held at a hotel. Sayers was accompanied by member of his leadership team including Ambati Venu, Vice President and GM for the Middle East and Saohail Matin, General Manager for Pakistan.
Sayers spoke at length on GSK’s commitment to Pakistan as an emerging market on which there will be extensive focus in the coming years. He explained the GSK has identified emerging market such as Pakistan as future growth drivers for the company.
“Pakistan offers a diverse population pool that has significant growth potential and is strongly registering on our consumer healthcare investment radars,” stated Ambati Venu.
He reiterated his belief that Pakistan would be one of the future growth markets not only for Middle East region but also for global business.
Sohail Matin said GSK Consumer Healthcare is a company guided by scientific innovation, values and consumer focus and these will be the driving force for the Company’s growth ambitions in Pakistan.